{
     "PMID": "24560603",
     "OWN": "NLM",
     "STAT": "MEDLINE",
     "DCOM": "20141203",
     "LR": "20161125",
     "IS": "1872-6240 (Electronic) 0006-8993 (Linking)",
     "VI": "1557",
     "DP": "2014 Apr 4",
     "TI": "Berberine was neuroprotective against an in vitro model of brain ischemia: survival and apoptosis pathways involved.",
     "PG": "26-33",
     "LID": "10.1016/j.brainres.2014.02.021 [doi] S0006-8993(14)00215-7 [pii]",
     "AB": "Berberine is an alkaloid derived from herb the Berberis sp. and has long-term use in Oriental medicine. Studies along the years have demonstrated its beneficial effect in various neurodegenerative and neuropsychiatric disorders. The subject of this study was to evaluate whether berberine protects against delayed neuronal cell death in organotypic hippocampal culture (OHC) exposed to oxygen and glucose deprivation (OGD) and the cell signaling mechanism related to its effect. Hippocampal slices were obtained from 6 to 8-days-old male Wistar rat and cultured for 14 days. Following, the cultures were exposed for 1h to OGD and then treated with Berberine (10 and 20muM). After 24h recovery, propidium iodide (PI) uptake was analyzed and a decrease was observed in PI uptake on OGD Ber-treated culture, which means a decrease in cellular death. Western blot analysis showed that proteins Akt, GSK3beta, ERK and JNK appear to play a role in berberine-mediated neuroprotection. Furthermore, capase-3 activity of OGD Ber-treated culture was diminished by control level in a fluorimetry assay. These findings suggest that berberine-mediated neuroprotection after ischemia involves Akt/GSK3beta/ERK 1/2 survival/apoptotic signaling pathway as well as JNK and caspase-3 activity inhibition.",
     "CI": [
          "Copyright (c) 2014 Elsevier B.V. All rights reserved."
     ],
     "FAU": [
          "Simoes Pires, Elisa Nicoloso",
          "Frozza, Rudimar Luiz",
          "Hoppe, Juliana Bender",
          "Menezes, Bruna de Melo",
          "Salbego, Christianne Gazzana"
     ],
     "AU": [
          "Simoes Pires EN",
          "Frozza RL",
          "Hoppe JB",
          "Menezes Bde M",
          "Salbego CG"
     ],
     "AD": "Programa de Pos-Graduacao em Ciencias Biologicas: Bioquimica, Departamento de Bioquimica, Instituto de Ciencias Basicas da Saude, UFRGS, Rua Ramiro Barcelos 2600, 90035.003 Porto Alegre, RS, Brazil. Electronic address: elisansp@gmail.com. Instituto de Bioquimica Medica, UFRJ, Av. Carlos Chagas Filho, 373, 21944-590 Rio de Janeiro, RJ, Brazil. Programa de Pos-Graduacao em Ciencias Biologicas: Bioquimica, Departamento de Bioquimica, Instituto de Ciencias Basicas da Saude, UFRGS, Rua Ramiro Barcelos 2600, 90035.003 Porto Alegre, RS, Brazil. Departamento de Bioquimica, Instituto de Ciencias Basicas da Saude, UFRGS, Rua Ramiro Barcelos 2600, 90035.003 Porto Alegre, RS, Brazil. Programa de Pos-Graduacao em Ciencias Biologicas: Bioquimica, Departamento de Bioquimica, Instituto de Ciencias Basicas da Saude, UFRGS, Rua Ramiro Barcelos 2600, 90035.003 Porto Alegre, RS, Brazil.",
     "LA": [
          "eng"
     ],
     "PT": [
          "Journal Article",
          "Research Support, Non-U.S. Gov't"
     ],
     "DEP": "20140219",
     "PL": "Netherlands",
     "TA": "Brain Res",
     "JT": "Brain research",
     "JID": "0045503",
     "RN": [
          "0 (Neuroprotective Agents)",
          "0I8Y3P32UF (Berberine)",
          "EC 2.7.11.1 (Glycogen Synthase Kinase 3 beta)",
          "EC 2.7.11.1 (Gsk3b protein, rat)",
          "EC 2.7.11.1 (Proto-Oncogene Proteins c-akt)",
          "EC 2.7.11.26 (Glycogen Synthase Kinase 3)",
          "EC 3.4.22.- (Casp3 protein, rat)",
          "EC 3.4.22.- (Caspase 3)",
          "IY9XDZ35W2 (Glucose)"
     ],
     "SB": "IM",
     "MH": [
          "Animals",
          "Apoptosis/*drug effects/physiology",
          "Berberine/*pharmacology",
          "Brain Ischemia/*drug therapy/physiopathology",
          "Caspase 3/metabolism",
          "Cell Survival/*drug effects/physiology",
          "Disease Models, Animal",
          "Dose-Response Relationship, Drug",
          "Glucose/deficiency",
          "Glycogen Synthase Kinase 3/metabolism",
          "Glycogen Synthase Kinase 3 beta",
          "Hippocampus/*drug effects/physiopathology",
          "Hypoxia/drug therapy/physiopathology",
          "In Vitro Techniques",
          "MAP Kinase Signaling System/drug effects/physiology",
          "Male",
          "Neuroprotective Agents/*pharmacology",
          "Proto-Oncogene Proteins c-akt/metabolism",
          "Rats",
          "Rats, Wistar"
     ],
     "OTO": [
          "NOTNLM"
     ],
     "OT": [
          "Akt/GSK3beta/ERK",
          "Berberine",
          "Caspase-3",
          "JNK",
          "Neuroprotection",
          "Oxygen and glucose deprivation"
     ],
     "EDAT": "2014/02/25 06:00",
     "MHDA": "2014/12/15 06:00",
     "CRDT": [
          "2014/02/25 06:00"
     ],
     "PHST": [
          "2013/09/02 00:00 [received]",
          "2014/02/05 00:00 [revised]",
          "2014/02/08 00:00 [accepted]",
          "2014/02/25 06:00 [entrez]",
          "2014/02/25 06:00 [pubmed]",
          "2014/12/15 06:00 [medline]"
     ],
     "AID": [
          "S0006-8993(14)00215-7 [pii]",
          "10.1016/j.brainres.2014.02.021 [doi]"
     ],
     "PST": "ppublish",
     "SO": "Brain Res. 2014 Apr 4;1557:26-33. doi: 10.1016/j.brainres.2014.02.021. Epub 2014 Feb 19.",
     "term": "hippocampus"
}